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alcohol reduction: A population survey of
adults in England
Emma Beard1,2*, Jamie Brown1,2, Susan Michie1, Eileen Kaner3, Petra Meier4 and Robert West2Abstract
Background: It is important for policy planning to chart the methods smokers and high-risk drinkers use to help
them change their behaviour. This study assessed prevalence of use, and characteristics of users, of support for
smoking cessation and alcohol reduction in England.
Methods: Data were used from the Smoking and Alcohol Toolkit Studies, which involve monthly face-to-face
computer-assisted interviews of adults aged 16+ in England. We included data collected between June 2014 and
July 2015 on 1600 smokers who had made at least one quit attempt and 911 high-risk drinkers (defined as scores
>8+ on the full AUDIT or 5+ on questions 1–3 of the AUDIT-C) who had made an attempt to cut down in the past
12 months. Participants provided information on their socio-demographic characteristics and use of aids during
their most recent quit attempt including pharmacotherapy, face-to-face counselling, telephone support, self-help
materials (digital and printed), and complementary medicine.
Results: A total of 60.3% of smokers used aids in the past year, compared with just 14.9% of high-risk drinkers.
Use of pharmacotherapy was high among smokers and very low among drinkers (56.0%versus1.2%). Use of other
aids was low for both behaviours: face-to-face counselling (2.6%versus4.8%), self-help materials (1.4%versus4.1%) and
complementary medicine (1.0%versus0.5%). Use of aids was more common among smokers aged 25–54 compared
with 16–24 year olds (25–34,ORadj1.49,p = 0.012; 35–44,ORadj1.93,p < 0.001; 35–44,ORadj1.93,p < 0.001; 45–54,ORadj1.66,
p = 0.008), with cigarette consumption >10 relative to <1 (10–20,ORadj2.47,p = 0.011; >20,ORadj4.23,p = 0.001), and less
common among ethnic minorities (ORadj0.69,p = 0.026). For alcohol reduction, use of aids was higher among ethnic
minority groups (ORadj2.41;p = 0.015), and those of social-grade D/E relative to AB (ORadj2.29,p = 0.012&ORadj3.13,p < 0.001).
Conclusion: In England, the use of pharmacotherapy is prevalent for smoking cessation but not alcohol reduction.
Other aids are used at a low rate, with face-to-face counselling being more common for alcohol reduction than
smoking cessation.
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Smoking and alcohol consumption contribute to more
than 7 million deaths per year worldwide and are associ-
ated with a wide range of chronic conditions [1–3].
National guidelines around the world recommend use of
evidence-based aids for alcohol misuse and tobacco
dependence to reduce this burden (e.g. England, Amer-
ica, Brazil, Uruguay and China) [4–7]. This includes a
combination of behavioural support and pharmacother-
apy [8, 9]. There are also a number of other aids avail-
able including self-help materials and complementary
alternative medicines [10–13]. It is important to know
what proportion of people make use of these aids in
order to help develop policies aimed at maximising their
impact. For example, if smokers are underusing Stop
Smoking Services, which is one of the most cost-
effective smoking cessation methods, Local Authorities
responsible for the services may be encouraged to
improve funding [8]. It is also important to understand
the characteristics of users of aids to help target services
effectively. This paper addresses those issues.
To our knowledge, no population survey has assessed
the use of aids for alcohol reduction in England. A com-
prehensive evaluation of the use of smoking treatments
was undertaken in 2008 [14]. However, given the changing
climate of tobacco control since that time a different popu-
lation profile may exist [15]. That study also did not report
on aids such as acupuncture and hypnotherapy, digital in-
terventions or self-help books. Thus this study attempted
to assess self-reported use of aids among smokers and
high-risk drinkers in England during 2014/2015. It also
aimed to establish the socio-demographic and smoking or
drinking characteristics profile of those using aids.
There are a number of reasons to believe that use of
treatments among smokers may have changed since 2008
in England. Nicotine replacement therapy (NRT) has been
licensed for both smoking cessation and smoking reduc-
tion, a wider range of pharmacological products are avail-
able on the market (e.g. electronic cigarettes), and control
of stop smoking services has moved from Primary Care
Trusts to Local Authorities [16–18]. Data from stop
smoking services suggests there has been a change in use
since 2008 [19] and use of electronic cigarettes has over
taken use of prescription medication [20].
There are several reasons why one may expect use of
aids for alcohol reduction to be lower than for smoking.
First, although the National Treatment Agency for Sub-
stance Misuse noted a rise in the number of adults re-
ceiving alcohol treatment in 2013–14 [9]; these services
are only targeted at those considered to be dependent
[21]. In contrast, all smokers, regardless of their cigarette
consumption, are advised to attend specialist smoking ces-
sation services if they wish to quit smoking [19]. Secondly,
health-care professionals are significantly more likely todiscuss an individual’s smoking status, than to offer advice
on their alcohol intake [22]. This may be related to differ-
ences in financial incentives, confidence in ability to provide
advice, and difficulty in the assessment of high-risk drinking
[22]. Thirdly, the evidence base for the efficacy of pharma-
cotherapy and counselling for smoking cessation is stronger
having been established across more than a hundred trials
[23–29]. In contrast, evidence is limited for the efficacy of
licensed medications in maintaining abstinence after de-
toxification from alcohol [30] and for the therapeutic bene-
fits of drugs (e.g. Baclofen) for alcohol withdrawal [31].
Clinical trials also do not currently support the use of be-
havioural counselling for high-risk drinking (e.g. motiv-
ational interviewing [32]); while the efficacy of self-help
groups have not been adequately evaluated [33]. A fourth
explanation may be that English stop smoking services are
currently more structured and less fragmented than local
alcohol services, partially as a consequence of a historically
greater focus on tobacco control in public health [34]. Fi-
nally, alcohol medications are only available on prescrip-
tion, while NRT and electronic cigarettes can be purchased
in shops and supermarkets. This has likely increased public
awareness, along with the advertisement of NRT products
in mainstream media since the 1990s [35].
In terms of the characteristics of users of support, the
literature suggests that older women are more likely to
seek help than younger men for a diverse range of
problems such as depression, substance abuse, physical
disabilities, and stressful life events [36–41]. Explana-
tions for this include women recognising problems
more readily than men, traditional attitudes about the
male gender role and heightened feelings of invincibil-
ity and propensity for risk-taking during young adult-
hood [42, 43]. These findings are largely supported by
the literature on treatment use for smoking and alco-
hol [14, 44–46], which also find that socio-economic
status (SES) and extent of substance dependency are
important. Lower social disadvantage higher cigarette
consumption and higher alcohol intake, are associated
with greater rates of support [47–51]. Studies on the
relationship between ethnicity and drug treatment use
suggest that those identifying as being of white ethni-
city are more likely to seek help than those of Black
and Asian ethnicities [45, 52].
In summary, this study aimed to assess the prevalence
of self-reported use of aids to stopping smoking and
reducing excessive alcohol consumption in England
and establish whether socio-demographic and drug use
characteristics differ among those using various aids.
Methods
Design
Data were collected on 28,521 participants who took
part in the Alcohol Toolkit Study (ATS) and Smoking
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Our included sample was the 25.0% (95%CI 24.5 to 25.5;
n = 7130) of participants classed as high-risk drinkers
(weighted: 26.5%) and 19.1% (95%CI 18.6 to 19.54; n =
5426) classed as smokers (weighted: 19.1%). The ATS
and STS involve monthly cross-sectional general house-
hold computer-assisted interviews, conducted by Ipsos
Mori as part of an omnibus survey, of approximately
1,800 adults aged 16+ and over in England. The baseline
survey uses a type of random location sampling, which
is a hybrid between random probability and simple
quota sampling. England is first split into over 170000
‘Output Areas’, comprising of approximately 300 house-
holds. These areas are then stratified according to ACORN
socio-demographic characteristics and geographic region
(http://www.caci.co.uk/acorn/).
The areas are then randomly allocated to interviewers,
who travel to their selected areas starting at a random
point and conduct the handheld computer-assisted in-
terviews with one member of the household until inter-
viewers achieve quotas on sex, age, working status and
tenure tailored to each area based on census data to
minimise differences in the probability of participation.
Each monthly survey typically includes ~150 localities.
For more details see www.smokinginengland.info and
www.alcoholinengland.info or the published protocols
[53, 54]. Participants from the STS appear to be repre-
sentative of the population in England, having similar
socio-demographic composition characteristics to large
national surveys based on probability samples such as
the Health Survey for England [54]. The representative-
ness of the alcohol-related parameters has yet to be for-
mally assessed, but appears to provide similar estimates
as other population surveysInclusion criteria
Our sample consisted of all those aged 16 and over who
reported being a smoker and/or met the criteria for a
high-risk drinker. Our focus was not on those who were
low to moderate risk drinkers, as policy within England
focuses on reducing consumption among those who are
drinking at hazardous or harmful levels.Measures
Socio-demographic characteristics
Age, gender, ethnicity and SES were measured. SES was
measured using social-grade derived from the National
Readership Survey social-grades system [55]: A: higher
managerial, administrative or professional; B: intermedi-
ate managerial, administrative or professional; C1: super-
visory or clerical and junior managerial administrative or
professional; C2: skilled manual workers; D: Semi and
unskilled manual workers; and E: Casual or lowest gradeworkers, pensioners and others who depend on the
welfare state for their income.
Smoking
Participants who reported that they smoked cigarettes
daily or non-daily answered the following questions:
1. How many serious attempts to stop smoking have
you made in the last 12 months? By serious attempt
I mean you decided that you would try to make sure
you never smoked again. Please include any attempt
that you are currently making and please include
any successful attempt made within the last year.
2. Which, if any, of the following did you try to help
you stop smoking during your most recent serious
quit attempt? [Nicotine replacement therapy on
prescription; Nicotine replacement therapy not on
prescription; Bupropion; Varenicline; Electronic
cigarettes; Attended one or more stop smoking
one-to-one counselling\advice\support sessions for
help with smoking; Attended a stop smoking group;
Phoned a smoking helpline; A self-help book or
booklet; Visited a website for smoking cessation;
Used an alcohol application ('app') on a handheld
computer (smartphone, tablet, PDA); Hypnotherapy;
Acupuncture; Nothing/willpower; Don’t know; Other
(please specify)]
All participants were asked to complete the Alcohol
Use Disorders Identification Test (AUDIT). The AUDIT
is used as a method of screening for alcohol use and has
validity, high internal consistency and good test-retest
reliability across gender, age and cultures [56–58]. The
full AUDIT consists of 10 questions: questions 1–3 deal
with alcohol consumption (AUDIT-C), 4–6 with alcohol
dependence and 7–10 with alcohol-related problems.
Participants scoring 8+ on the full AUDIT [59] or 5+
on questions 1–3 of the AUDIT-C [60, 61], which indi-
cates a hazardous or harmful level of alcohol consump-
tion, answered the following questions:
3. How many attempts to restrict your alcohol
consumption have you made in the last 12 months
(e.g. by drinking less, choosing lower strength
alcohol or using smaller glasses)? Please include all
attempts you have made in the last 12 months,
whether or not they were successful, AND any
attempt that you are currently making.
4. Which, if any, of the following did you use to try to
help restrict your alcohol consumption during the
most recent attempt? [Any medicines (e.g., acamprosate
(Campral), disulfiram (Antabuse), nalmefene (Selincro);
Attended one or more one-to-one or group
counselling\advice\support sessions for help with
Table 1 Number of smokers reporting a recent quit attempt
and high-risk drinkers reporting an attempt to cut down stratified
by socio-demographic and drug-related characteristics
Smokers having made
a recent quit attempt
High-risk drinkers having made
a recent attempt to cut down
Sex %(n)
Male 48.8 (781) 63.3 (577)
Female 51.2 (819) 36.7 (334)
Age (years)
16–24 20.9 (335) 14.9 (136)
25–34 23.1 (370) 13.5 (123)
35–44 17.4 (279) 17.0 (155)
45–54 16.2 (260) 22.4 (204)
55–64 12.4 (199) 18.7 (170)
65 and over 9.8 (157) 13.5 (123)
Social grade
AB 11.1 (177) 34.5 (314)
C1 26.6 (425) 34.1 (311)
C2 23.5 (376) 13.7 (125)
D 19.1 (306) 8.9 (81)
E 19.8 (316) 8.8 (80)
Ethnicity %(n)
White 88.3 (1410) 94.7 (859)
Non–white 11.7 (186) 5.3 (48)
Cigarette consumption per day %(n)
<1 2.4 (38) NA
≥ 1–5 25.4 (402) NA
>5–10 36.7 (582) NA
>10–20 30.9 (490) NA
>20 4.5 (72) NA
Units of alcohol on a typical day
1–2 NA 13.2 (120)
3–4 NA 37.6 (342)
5–6 NA 21.2 (193)
7–9 NA 13.1 (199)
10+ NA 14.9 (135)
Total %(n) 29.5 (1600) 12.8 (911)
NA not applicable
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centre for help with drinking; Consulted a community
pharmacist for help with drinking; Phoned a helpline
for help with drinking (e.g. DrinkLine); An alcohol
self-help book or booklet; Visited a website for help
with drinking; Used an alcohol application ('app') on a
handheld computer (smartphone, tablet, PDA);
Hypnotherapy for help with drinking; Acupuncture
for help with drinking; Nothing/willpower; Don’t
know; Other (please specify)]
Analysis
All analyses were conducted using R version 3.1.2. Key
prevalence figures were calculated both unweighted and
weighted to match the population in England. Data were
weighted using a rim (marginal) weighting technique.
This involves an iterative sequence of weighting adjust-
ments whereby separate nationally representative target
profiles are set (for gender, working status, children in
the household, age, social-grade and region). This
process is then repeated until all variables match the
specified targets. For more details see [53]. Linear-by-
linear X2 tests were used to check for temporal trends in
the data that may need to be taken into account in the
main analysis. The statistically significant differences in
use of the various aids was calculated using Pearson’s X2
tests for the association with sex and ethnicity, and using
linear-by-linear X2 tests for the association with age,
social-grade, number of units consumed on a typical day,
and cigarette consumption per day. Subsequently, we used
generalised linear modelling to regress the use of licensed
medication or behavioural support and use of any aid for
smoking cessation or alcohol reduction (defined as use of
licensed medication, face-to-face counselling, telephone
helpline [and NRT over-the-counter for smokers]) on the
factors age, sex, social-grade, ethnicity and number of cig-
arettes/units of alcohol consumed. The quasi-binomial
family was specified as there was evidence of overdisper-
sion. As linearity of the logit was violated (assessed using
the Box-Tidwell test), age was transformed into a categor-
ical variable.
Results
Thirty per cent of smokers (95%CI 28.3 to 30.7; n = 1600)
reported having made at least one quit attempt in the past
12 months; while 12.8% (95%CI 12.0 to 13.6; n = 911) of
high-risk drinkers reported at least one previous attempt to
cut down. Table 1 shows the characteristics of participants
who reported a recent quit attempt and/or were high-risk
drinkers and had attempted to reduce their intake.
Overall prevalence of aid use
Linear-by-linear X2 analyses did not reveal any evidence
for temporal trends in the overall use of aids forattempts to quit smoking or attempts to reduce alcohol
intake. There were significant trends for some of the
individual aids including NRT use over-the-counter and
telephone support for alcohol consumption (see Additional
file 1: Table S1). Thus the decision to pool the cross-
sectional data was valid and time was not included as a
covariate in the analysis of the association between use of
aids and socio-demographic and drug-use characteristics.
Table 2 (bottom row) shows that 60.3% of those mak-
ing a recent quit attempt used an aid to support them,
Table 2 Proportion of smokers using aids during their most recent quit attempt stratified by socio-demographic and smoking characteristics
Nothing/
willpower
Combination of aids Licensed medication
Strata Any aid Licensed medication or
behavioural support
Any prescription
medication
Any licensed
medication
Any behavioural
support
Any face-to-
face support
Any self-
help
NRT on
prescription
Varenicline Buproprion NRT over-the-
counter
Sex %(n) * * *
Male 40.5 (316) 58.1 (454) 31.0 (242) 10.8 (84) 30.3 (237) 1.5 (12) 1.5 (12) 1.5 (12) 5.4 (42) 5.0 (39) 0.8 (6) 20.5 (160)
Female 35.3 (289) 62.4 (511) 32.2 (264) 12.2 (100) 31.3 (256) 3.5 (29) 3.5 (29) 1.3 (11) 4.9 (40) 6.5 (53) 1.3 (11) 20.1 (165)
Age (years) *** *** *** *** *** ** ** * **
16–24 47.2 (158) 50.4 (169) 17.0 (57) 4.2 (14) 16.4 (55) 1.2 (4) 1.2 (4) 2.7 (9) 1.8 (6) 2.4 (8) 0.0 (0) 12.8 (43)
25–34 39.2 (145) 58.1 (215) 27.3 (101) 9.2 (34) 26.2 (97) 1.6 (6) 1.6 (6) 1.1 (4) 5.4 (20) 3.5 (13) 0.5 (2) 17.8 (66)
35–44 31.5 (88) 65.9 (184) 36.9 (103) 14.3 (40) 36.9 (103) 2.9 (8) 2.9 (8) 1.4 (4) 3.9 (11) 10.0 (28) 0.7 (2) 24.4 (68)
45–54 31.5 (82) 67.7 (176) 40.8 (106) 16.9 (44) 39.6 (103) 3.5 (9) 3.5 (9) 1.5 (4) 8.5 (22) 6.9 (18) 2.7 (7) 23.1 (60)
55–64 35.2 (70) 64.3 (128) 38.7 (77) 15.1 (30) 36.7 (73) 5.0 (10) 5.0 (10) 0.5 (1) 8.0 (16) 6.5 (13) 1.0 (2) 23.1 (46)
65 and over 39.5 (62) 59.2 (93) 39.5 (62) 14.0 (22) 39.5 (62) 2.5 (4) 2.5 (4) 0.6 (1) 4.5 (7) 7.6 (12) 2.5 (4) 26.8 (42)
Social grade
AB 37.3 (66) 59.9 (106) 34.5 (61) 16.4 (29) 33.9 (60) 2.8 (5) 2.8 (5) 0.6 (1) 8.5 (15) 7.9 (14) 0.6 (1) 18.1 (32)
C1 39.1 (166) 59.8 (254) 31.1 (132) 11.5 (49) 30.6 (130) 1.4 (6) 1.4 (6) 2.4 (10) 3.3 (14) 7.1 (30) 1.4 (6) 19.5 (83)
C2 38.0 (143) 60.4 (227) 29.8 (112) 10.6 (40) 29.0 (109) 2.9 (11) 2.9 (11) 1.1 (4) 5.6 (21) 4.8 (18) 0.8 (3) 19.7 (74)
D 35.9 (110) 61.1 (187) 30.7 (94) 9.8 (30) 29.1 (89) 2.9 (9) 2.9 (9) 1.6 (5) 4.2 (13) 5.6 (17) 0.7 (2) 20.9 (64)
E 38.0 (120) 60.4 (191) 33.9 (107) 11.4 (36) 33.2 (105) 3.2 (10) 3.2 (10) 0.9 (3) 6.0 (19) 4.1 (13) 1.6 (5) 22.8 (72)
Ethnicity %(n) ** **
White 36.4 (513) 61.8 (871) 32.0 (451) 11.8 (167) 31.2 (440) 2.6 (36) 2.6 (36) 1.6 (22) 5.2 (73) 6.1 (86) 1.1 (15) 20.4 (288)
Non-white 48.4 (90) 49.5 (92) 28.5 (53) 8.6 (16) 27.4 (51) 2.2 (4) 2.2 (4) 0.5 (1) 4.3 (8) 3.2 (6) 1.1 (2) 19.4 (36)
Cigarette consumption
per day %(n)
*** *** *** *** *** ***
<1 55.3 (21) 44.7 (17) 21.1 (8) 5.3 (2) 21.1 (8) 0.0 (0) 0.0 (0) 2.6 (1) 2.6 (1) 2.6 (1) 0.0 (0) 15.8 (6)
≥ 1–5 46.0 (185) 51.7 (208) 23.1 (93) 6.7 (27) 22.6 (91) 2.0 (8) 2.0 (8) 2.2 (9) 4.2 (17) 2.2 (9) 0.5 (2) 17.2 (69)
>5–10 40.0 (233) 57.9 (337) 30.8 (179) 10.3 (60) 29.9 (174) 2.2 (13) 2.2 (13) 0.9 (5) 4.6 (27) 5.2 (30) 0.7 (4) 19.9 (116)
>10–20 30.2 (148) 68.4 (335) 39.6 (194) 16.7 (82) 38.6 (189) 3.7 (18) 3.7 (18) 1.4 (7) 6.5 (32) 9.2 (45) 1.8 (9) 23.3 (114)
>20 18.1 (13) 79.2 (57) 38.9 (28) 16.7 (12) 37.5 (27) 2.8 (2) 2.8 (2) 1.4 (1) 5.6 (4) 9.7 (7) 2.8 (2) 22.2 (16)
Total %(n) 37.8 (605) 60.3 (965) 31.6 (506) 11.5 (184) 30.8 (493) 2.6 (41) 2.6 (41) 1.4 (23) 5.1 (82) 5.8 (92) 1.1 (17) 20.3 (325)
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Table 2 Proportion of smokers using aids during their most recent quit attempt stratified by socio-demographic and smoking characteristics (Continued)
Electronic cigarettes Behavioural support Self-help Complementary
alternative medicine
Other
Strata Group counselling Individual counselling Telephone helpline Printed Digital
Sex %(n) *
Male 26.8 (209) 0.8 (6) 0.9 (7) 0.0 (0) 0.0 (0) 1.5 (12) 1.3 (10) 2.4 (19)
Female 31.4 (257) 1.7 (14) 2.2 (18) 0.0 (0) 0.0 (0) 1.3 (11) 0.7 (6) 2.6 (21)
Age (years) * *
16–24 31.3 (105) 0.9 (3) 0.3 (1) 0.0 (0) 0.0 (0) 2.7 (9) 0.3 (1) 2.7 (9)
25–34 30.3 (112) 1.1 (4) 0.5 (2) 0.0 (0) 0.0 (0) 1.1 (4) 0.3 (1) 2.2 (8)
35–44 33.0 (92) 1.4 (4) 2.2 (6) 0.0 (0) 0.0 (0) 1.4 (4) 0.7 (2) 0.7 (2)
45–54 27.7 (72) 1.2 (3) 2.7 (7) 0.0 (0) 0.0 (0) 1.5 (4) 1.9 (5) 3.8 (10)
55–64 28.1 (56) 3.0 (6) 2.5 (5) 0.0 (0) 0.0 (0) 0.5 (1) 2.0 (4) 2.5 (5)
65 and over 18.5 (29) 0.0 (0) 2.5 (4) 0.0 (0) 0.0 (0) 0.6 (1) 1.9 (3) 3.8 (6)
Social grade
AB 27.7 (49) 0.6 (1) 2.8 (5) 0.0 (0) 0.0 (0) 0.6 (1) 0.6 (1) 2.3 (4)
C1 29.6 (126) 0.5 (2) 1.2 (5) 0.0 (0) 0.0 (0) 2.4 (10) 1.2 (5) 2.6 (11)
C2 30.6 (115) 1.3 (5) 1.6 (6) 0.0 (0) 0.0 (0) 1.1 (4) 1.9 (7) 1.3 (5)
D 30.1 (92) 2.0 (6) 1.3 (4) 0.0 (0) 0.0 (0) 1.6 (5) 1.0 (3) 2.6 (8)
E 26.6 (84) 1.9 (6) 1.6 (5) 0.0 (0) 0.0 (0) 0.9 (3) 0.0 (0) 3.8 (12)
Ethnicity %(n) *
White 30.1 (425) 1.3 (19) 1.5 (21) 0.0 (0) 0.0 (0) 1.6 (22) 1.3 (10) 2.4 (19)
Non-white 22.0 (41) 0.5 (1) 1.6 (3) 0.0 (0) 0.0 (0) 0.5 (1) 0.7 (6) 2.6 (21)
Cigarette consumption
per day %(n)
*
<1 18.4 (7) 0.0 (0) 0.0 (0) 0.0 (0) 0.0 (0) 2.6 (1) 0.0 (0) 2.6 (1)
≥ 1–5 26.4 (106) 0.5 (2) 1.7 (7) 0.0 (0) 0.0 (0) 2.2 (9) 0.7 (3) 2.7 (11)
>5–10 28.2 (164) 0.9 (5) 1.5 (9) 0.0 (0) 0.0 (0) 0.9 (5) 0.5 (3) 2.1 (12)
>10–20 30.6 (150) 2.2 (11) 1.8 (9) 0.0 (0) 0.0 (0) 1.4 (7) 1.6 (8) 2.4 (12)
>20 44.4 (150) 2.8 (2) 0.0 (0 0.0 (0) 0.0 (0) 1.4 (1) 2.8 (2) 4.2 (3)
Total %(n) 29.1 (466) 1.3 (20) 1.6 (25) 0.0 (0) 0.0 (0) 1.4 (23) 1.0 (16) 2.5 (40)
Figures are presented as % (n) within stratum; those who reported that they used hypnosis or acupuncture were classed as having used an alternative complementary medicine; those using a website or mobile
phone application were grouped as having used an digital intervention; any aid includes all aids listed; any prescription medication includes NRT on prescription, varenilcine and bupropion; any licensed medication
includes any prescription medication and NRT over-the-counter; any behavioural support includes any face-to-face support and telephone helpline; any face-to-face support includes group counselling, individual
counselling and telephone helpline; any self-help includes printed and digital interventions; P < 0.05, **P < 0.01, ***P < 0.001 (by linear-by-linear X2 tests or Pearson’s X2 test)
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support or formal behavioural support. A significant ma-
jority of smokers had used electronic cigarettes (29.1%,
n = 466). The most commonly used licensed medication
was NRT over-the-counter (20.3%, n = 325), followed by
5.8% (n = 92) using varenicline, 5.1% (n = 82) using NRT
on prescription and 1.1% (n = 17) using bupropion. A
small minority of recent quitters used self-help materials
and alternative complementary medicine.
Table 3 (bottom row) shows that a substantially smaller
number of those cutting down on alcohol used an aid
(14.9%, n = 136) relative to those attempting to quit smok-
ing, with just 5.7% using medically licensed pharmacother-
apy or behavioural support. Use of self-help materials was
more common than for quitting smoking (4.1%, n= 38),
but fewer used complementary alternative medicines
(0.5%, n = 5).
Associations between aid use and socio-demographic and
smoking characteristics
A higher proportion of female (3.5%) than male (1.5%)
smokers who had tried to quit smoking in the past
12 months had used behavioural support (Table 2); while
a higher proportion of recent male quitters (40.5%) re-
ported using willpower alone than recent female quitters
(35.3%). There was an increase in the use of some form of
smoking cessation aid generally (and medically licensed
pharmacotherapy or behavioural support) with age, which
appeared to stem from the greater use of medication
among older age groups. Those of white ethnicity were
more likely to use support, with the difference resulting
mainly from a greater use of electronic cigarettes.
Electronic cigarette users also tended to be younger. In
contrast, those of non-white ethnicity were more likely
to report use of will-power alone. Use of aids generally
(and medically licensed pharmacotherapy or behav-
ioural support) appeared to be more common among
those smoking a greater number of cigarettes per day,
again this appeared to stem from a greater use of
licensed medication. There were no differences as a
function of social-grade.
A greater proportion of female (9.0%) than male
(5.5%) drinkers who had attempted to cut down on their
alcohol had used a different aid than those listed (Table 3).
Use of face-to-face support decreased with increasing age,
while use of most aids was more common among lower
social-grades. For example, 17.5% of those classed as
social-grade E used medically licensed pharmacotherapy
and behavioural support compared with just 1.9% of those
in social-grade AB. In relation to ethnicity, those of non-
white ethnicity were more likely to use an aid than those
of white ethnicity (29.2% versus 14.1%). This appeared to
stem from a greater use of behavioural support and self-
help. There were no differences as a function of thenumber of units consumed on a typical day expect among
those using a specialist clinic, with the prevalence of use
highest among those consuming more than 10 units.
Table 4 shows the multiple logistic regression models
in which each factor associated with use of aids and li-
censed medication or behavioural support were adjusted
for other factors. The odds of using aids, licensed medi-
cation or behavioural support for smoking cessation was
higher among all age groups relative to those aged 16 to
24 (expect those aged 65+). The odds of using aids and
licensed medication or behavioural support for smoking
cessation were also higher among those smoking more
than 10 cigarettes per day relative to those smoking less
than 1; while use of aids generally was lower among eth-
nic minority groups. In contrast, the use of aids and li-
censed medication or behavioural support to cut down
on drinking was higher among those of social grade D
and E and those of non-white ethnicity.
Discussion
A majority of smokers trying to stop used some form of
aid, whereas this was true for only a small minority of
people trying to reduce their alcohol consumption.
Pharmacological support was by far the most commonly
used aid for smokers but was used very little for alcohol
reduction. Use of face-to-face counselling was low in both
groups but slightly higher for people reducing their
alcohol consumption than smokers trying to stop. The use
of support was greater among older smokers with higher
cigarette consumption, and lower among those of
non-white ethnicity. In contrast, use of aids during
attempts to reduce alcohol intake was more common
among ethnic minority groups and those of social-grades
D and E relative to AB.
The finding that only 1/3rd of smokers in England
were using medically licensed pharmacotherapy or be-
havioural support is significantly lower than the 51.2% in
2008 [14], but is close to the estimated 36.1% of smokers
using treatment in the US [46]. This appears to reflect a
decline in use of behavioural support, use of prescription
medication and use of NRT over-the-counter; findings
which are in line with audit data from the English Stop
Smoking Services [19]. Sales of NRT have been decreas-
ing steadily in recent years [20], a trend which does not
appear to be a consequence of the rise in electronic ciga-
rettes but may reflect a longer term disengagement from
licensed nicotine products [62]. The reduction in use of
behavioural support may be attributable to the move of
commissioning of stop smoking services from Primary
Care Trusts to Local Authorities, which has created a
fragmented system of support [63].
In line with surveys from the US, Europe, and Brazil
[47, 64, 65], only a small proportion of participants used
aids during attempts to reduce their alcohol intake.
Table 3 Proportion of drinkers using aids during their most recent attempt to cut down stratified by socio-demographic and drinking characteristics
Combination of aids Behavioural support Self-help
Strata Nothing/
Willpower
Any aid Licensed
medication or
behavioural
Licensed
medication
Any behavioural
support
Any face-to-
face support
Any self-
help
Group
counselling
Specialist
clinic
Community
pharmacist
Telephone
helpline
Printed Digital Complementary
alternative
medicine
Other
Sex %(n) * *
Male 79.0 (456) 13.7 (79) 5.9 (34) 0.9 (5) 5.7 (33) 5.5 (32) 4.0 (23) 2.4 (14) 3.8 (22) 0.5 (3) 0.7 (4) 1.6 (9) 2.9 (17) 0.5 (3) 5.5 (32)
Female 76.6 (256) 17.1 (57) 5.4 (18) 1.8 (6) 3.9 (13) 3.6 (12) 3.3 (11) 2.4 (8) 0.9 (3) 0.6 (2) 0.6 (2) 1.5 (5) 2.1 (7) 0.6 (2) 9.0 (30)
Age (years) *
16–24 82.4 (112) 11.8 (16) 7.4 (10) 0.7 (1) 6.6 (9) 6.6 (9) 4.4 (6) 1.5 (2) 3.7 (5) 1.5 (2) 0.7 (1) 2.9 (4) 2.9 (4) 0.0 (0) 3.7 (5)
25–34 80.5 (99) 14.6 (18) 5.7 (7) 0.8 (1) 4.9 (6) 4.9 (6) 4.1 (5) 2.4 (3) 2.4 (3) 0.0 (0) 0.0 (0) 0.8 (1) 4.1 (5) 0.8 (1) 5.7 (7)
35–44 74.2 (115) 20.6 (32) 9.7 (15) 2.6 (4) 7.7 (12) 7.7 (12) 4.5 (7) 3.9 (6) 4.5 (7) 0.6 (1) 0.6 (1) 1.9 (3) 2.6 (4) 0.0 (0) 8.4 (13)
45–54 79.4 (162) 14.7 (30) 5.4 (11) 1.5 (3) 5.4 (11) 4.9 (10) 4.9 (10) 3.4 (7) 2.9 (6) 1.0 (2) 1.5 (3) 2.0 (4) 2.9 (6) 1.5 (3) 5.9 (12)
55–64 78.2 (113) 13.5 (23) 3.5 (6) 0.6 (1) 3.5 (6) 3.5 (6) 2.4 (4) 1.8 (3) 2.4 (4) 0.0 (0) 0.0 (0) 0.6 (1) 2.4 (4) 0.0 (0) 8.2 (14)
65 and over 74.0 (91) 13.8 (17) 2.4 (3) 0.8 (1) 1.6 (2) 0.8 (1) 1.6 (2) 0.8 (1) 0.0 (0) 0.0 (0) 0.8 (1) 0.8 (1) 0.8 (1) 0.8 (1) 8.9 (11)
Social grade *** *** *** *** *** *** ** *** ** **
AB 80.6 (253) 12.1 (38) 1.9 (6) 0.3 (1) 1.9 (6) 1.9 (6) 2.5 (8) 1.6 (5) 1.0 (3) 0.3 (1) 0.3 (1) 0.6 (2) 2.2 (7) 0.0 (0) 8.0 (25)
C1 81.4 (253) 12.5 (39) 5.1 (16) 1.3 (4) 4.2 (13) 4.2 (13) 3.2 (10) 1.9 (6) 1.9 (6) 0.6 (2) 0.0 (0) 1.3 (4) 2.3 (7) 0.6 (2) 5.5 (17)
C2 79.3 (99) 12.8 (16) 4.0 (5) 0.0 (0) 4.0 (5) 4.0 (5) 3.2 (4) 0.8 (1) 2.4 (3) 0.8 (1) 0.8 (1) 1.6 (2) 2.4 (3) 1.6 (2) 5.6 (7)
D 72.8 (59) 23.5 (19) 13.6 (11) 0.0 (0) 13.6 (11) 11.1 (9) 6.2 (5) 4.9 (4) 6.2 (5) 1.2 (1) 2.5 (2) 2.7 (3) 3.7 (3) 1.2 (1) 7.4 (6)
E 60.0 (48) 30.0 (24) 17.5 (14) 7.5 (6) 13.8 (11) 13.8 (11) 8.8 (7) 7.5 (6) 10.0 (8) 0.0 (0) 2.5 (2) 3.8 (3) 5.0 (4) 0.0 (0) 8.8 (7)
Ethnicity %(n) * ** ** *** ** ** * * **
White 78.9 (678) 14.1 (121) 5.0 (43) 1.2 (10) 4.3 (37) 4.2 (36) 3.3 (28) 2.0 (17) 2.8 (24) 0.3 (3) 0.5 (4) 1.4 (12) 2.2 (19) 0.6 (5) 6.9 (59)
Non-white 64.6 (31) 29.2 (14) 16.7 (8) 2.1 (1) 16.7 (8) 14.6 (7) 12.5 (6) 8.3 (4) 2.1 (1) 4.2 (2) 4.2 (2) 4.2 (2) 10.4 (5) 0.0 (0) 6.2 (3)
Units of alcohol
on a typical day
**
1–2 77.9 (95) 14.8 (18) 5.8 (7) 2.5 (3) 5.0 (6) 6.6 (8) 1.7 (2) 2.5 (3) 4.2 (5) 0.0 (0) 0.8 (1) 0.8 (1) 1.6 (2) 1.6 (2) 5.7 (7)
3–4 76.9 (263) 15.2 (52) 4.7 (16) 0.3 (1) 4.7 (16) 4.7 (16) 3.8 (13) 2.9 (10) 1.5 (5) 0,3 (1) 0.3 (1) 1.5 (5) 2.6 (9) 0.3 (1) 8.2 (28)
5–6 76.7 (148) 16.6 (32) 4.1 (8) 1.0 (2) 3.1 (6) 2.6 (5) 5.7 (11) 1.0 (2) 1.0 (2) 0.5 (1) 0.5 (1) 3.1 (6) 3.6 (7) 0.0 (0) 8.3 (16)
7–9 82.4 (98) 12.6 (15) 5.0 (6) 0.8 (1) 4.2 (5) 3.4 (4) 3.4 (4) 0.0 (0) 1.7 (2) 1.7 (2) 0.8 (1) 0.8 (1) 3.4 (4) 0.8 (1) 4.2 (5)
10+ 108 (80) 14.1 (19) 9.6 (13) 3.0 (4) 8.1 (11) 8.1 (11) 2.2 (3) 3.7 (5) 6.7 (9) 0.7 (1) 1.5 (2) 0.7 (1) 1.5 (2) 0.7 (1) 4.4 (6)
Total %(n) 78.2 (712) 14.9 (136) 5.7 (52) 1.2 (11) 5.0 (46) 4.8 (44) 3.7 (34) 2.4 (22) 2.7 (25) 0.5 (5) 0.7 (6) 1.5 (14) 2.6 (24) 0.5 (5) 6.8 (62)
Figures are presented as % (n) within stratum; those who reported that they used hypnosis or acupuncture were classed as having used an alternative complementary medicine; those using a website or mobile
phone application were grouped as having used an digital intervention; any aid includes all aids listed; any behavioural support includes any face-to-face support and telephone helpline; any face-to-face support in-
cludes group counselling, specialist clinic and community pharmacist; any self-help includes printed and digital interventions; P < 0.05, **P < 0.01, ***P < 0.001 (by linear-by-linear X2 tests or Pearson’s X2 test)
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Table 4 Multiple logistic regression model regarding the use of aids and licensed medication and/or behavioural specifically (yes versus no) on socio-demographic and
behaviour-related factors in smokers making a recent quit attempt and drinkers attempting to cut down
Use of aids among smokers
attempting to quit (n = 965
versus n = 635)
Use of aids among drinkers attempting
to cut down (n = 136 versus n = 775)
Use of licensed medication or behavioural
among smokers attempting to quit
(n = 506 versus n = 1094)
Use of licensed medication or behavioural among
drinkers attempting to cut down (n = 52 versus
n = 859)
95%CI 95%CI 95%CI 95%CI
OR Lower Upper P OR Lower Upper P OR Lower Upper P OR Lower Upper P
Sex %(n)
Male 1 1 1 1
Female 1.14 0.93 1.43 0.192 1.24 0.84 1.85 0.278 1.04 0.83 1.30 0.748 0.89 0.44 1.73 0.731
Age (years)
16–24 1 1 1 1
25–34 1.49 1.09 2.03 0.012 1.31 0.61 2.83 0.491 1.99 1.37 2.92 <0.001 0.81 0.24 2.47 0.716
35–44 1.93 1.38 2.72 <0.001 1.98 1.01 4.01 0.050 2.94 2.00 4.36 <0.001 1.63 0.64 4.27 0.308
45–54 1.93 1.36 2.74 <0.001 1.43 0.72 2.90 0.313 3.31 2.25 4.93 <0.001 1.00 0.36 2.76 0.992
55–64 1.66 1.14 2.42 0.008 1.36 0.66 2.85 0.412 3.10 2.05 4.72 <0.001 0.77 0.23 2.39 0.661
65 and over 1.35 0.91 2.01 0.135 1.47 0.66 3.26 0.345 3.19 2.06 4.98 <0.001 0.52 0.10 2.03 0.379
Social grade
AB 1 1 1 1 1 1
C1 1.13 0.77 1.64 0.534 1.08 0.65 1.78 0.766 1.09 0.74 1.62 0.656 2.30 0.86 6.99 0.112
C2 1.03 0.70 1.50 0.882 1.06 0.54 1.99 0.860 0.88 0.59 1.31 0.530 1.81 0.47 6.58 0.365
D 1.06 0.71 1.58 0.762 2.29 1.19 4.34 0.012 1.02 0.67 1.55 0.928 6.57 2.24 21.17 0.001
E 0.99 0.66 1.47 0.951 3.13 1.69 5.73 <0.001 1.12 0.74 1.69 0.598 8.63 3.02 27.40 <0.001
Ethnicity
%(n) 1 1 1 1 1 1
White
Non-white
0.69 0.50 0.96 0.026 2.51 1.23 4.90 0.009 1.00 0.69 1.43 0.996 4.01 1.51 9.68 0.003
Cigarette
consumption 1 1 1 - - - -
per day %(n) 1.30 0.64 2.62 0.466 - - - - 1.23 0.56 3.01 0.631 - - - -
<1 1.66 0.84 3.34 0.147 - - - - 1.82 0.84 4.41 0.153 - - - -
≥1-5 2.47 1.23 5.00 0.011 - - - - 2.50 1.15 6.08 0.029 - - - -
>5-10 4.23 1.77 10.47 0.001 - - - - 2.26 0.91 6.06 0.089 - - - -
>10-20
>20
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Table 4 Multiple logistic regression model regarding the use of aids and licensed medication and/or behavioural specifically (yes versus no) on socio-demographic and
behaviour-related factors in smokers making a recent quit attempt and drinkers attempting to cut down (Continued)
Units of - - - -
alcohol on a - - - - 1 - - - - 1
typical day - - - - 1.16 0.64 2.18 0642 - - - - 0.91 0.34 2.78 0.856
1–2 - - - - 1.20 0.63 2.36 0.593 - - – - 0.62 0.19 2.09 0.420
3–4 - - - - 0.94 0.43 2.04 0.875 - - - - 0.85 0.24 3.07 0.804
5–6 - - - - 1.04 0.48 2.23 0.928 - - - - 1.46 0.248 4.87 0.519
7–9
10+
Note: licensed medication and/or behavioural for smoking cessation includes prescription medication, NRT over-the-counter, face-to-face counselling and telephone helpline; licensed medication and/or behavioural for
alcohol includes licensed medication, face-to-face support and telephone helpline
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ness [66, 67]. For example, many drinkers are unaware
that they are consuming alcohol at harmful levels, and
few receive advice from healthcare professionals to
counteract this [22, 68]. In contrast, most smokers ac-
knowledge that cigarettes are harmful to their health
[69]. Thus there is a need for increasing intervention
rates among high risk drinkers [70, 71]. These discrepan-
cies may stem from a social and cultural acceptance of
drinking in contrast to the stigmatisation of smoking
[72]; alcohol marketing and promotion [73], or some of
the adverse consequences of alcohol consumption not
being evaluated in a negative manner [74].
The majority of the difference in use of aids among
smokers and high-risk drinkers was attributed to use of li-
censed medication. The less prevalent use among drinkers
likely results from availability, with medications to prevent
alcohol withdrawal symptoms only available on prescrip-
tion and targeted at the most dependent drinkers. In con-
trast, smoking pharmacotherapy is available on
prescription and over-the-counter [27, 28, 35, 66, 67]. Use
of electronic cigarettes was also high among this sample.
Studies suggest that electronic cigarettes may be a suitable
substitute for traditional tobacco containing products
[24, 25, 75]. In contrast, the finding that use of face-to-
face support among smokers was lower than that for al-
cohol reduction is surprising given that England has a
national network of stop-smoking clinics that are quite
heavily promoted. This is of concern since both group
and individual behavioural support appear to be effica-
cious in promoting quit attempts and ensuring the suc-
cess of those attempts [27]. Thus, it will be important
to find out how its use can be increased. A significantly
greater minority of high-risk drinkers were also using
self-help materials. Policy makers should take note of
this as it may reflect a strong preference for aids which
do not require one to engage in face-to-face behavioural
support [76].
It is perhaps unsurprising that smokers with higher
cigarette consumption had greater odds of reporting use
of licensed medication and/or behavioural support and
aids generally. More dependent smokers may be more
inclined to seek help as a consequence of continued fail-
ures to stop and the experience of stronger withdrawal
symptoms [76]. In contrast, despite specialist alcohol
services being aimed at more dependent drinkers, no as-
sociation was found with the average number of units
consumed per day. This may reflect the failure of GPs to
identify and refer the most dependent drinkers [22], the
fact that alcohol dependency is multifaceted and cannot be
measured accurately with a single item [58], or the cross-
sectional nature of study, whereby any reduction is pre-
cluded by the fact that those seeking treatment were of
higher dependency initially. The finding that those of olderage were more likely to seek help is consistent with previous
studies, although the effect of gender was much weaker [14,
36, 42]. The lack of association between licensed medication
and/or behavioural support for smoking cessation and
social-grade may reflect the fact that those from lower
social-grades do not need to pay for pharmacotherapy pre-
scriptions. In contrast, high-risk drinkers of lower SES and
of non-white ethnicity were more likely to seek help. This
could be due to cultural norms regarding alcohol use, with
greater stigmatisation among minority ethnic groups leading
to a higher motivation to seek help. Research is also accu-
mulating to suggest that those of lower social-grades experi-
ence greater harm from their alcohol use and report higher
dependency [77].
The study had several limitations. First, there is a risk that
respondents will underestimate or fail to report their
drinking and smoking and use of aids. Secondly, the find-
ings are limited to a single country, albeit one from which
useful lessons may be learned internationally given its
unique approach to treatment provision. Thirdly, there
are intrinsic limitations to population surveys that warrant
caution in extrapolating to populations including the
under-representation of students, the homeless and other
vulnerable populations. Fourthly, this study was limited to
investigating the overall prevalence of use of aids by
smokers and high-risk drinkers. Given the strong asso-
ciation between tobacco and alcohol use [78], research
into the use of aids to quitting smoking and reducing
excessive alcohol consumption by smokers consuming
excessive alcohol use could also be informative. Finally,
conclusions regarding the effectiveness of various aids
cannot be made due to the cross-sectional design and
the exclusion of those who have successfully quit smok-
ing or reduced their alcohol consumption to low/mod-
erate levels. This study does provide an indication of
the current prevalence of use of aids and the character-
istics of those most likely to opt for help during at-
tempts to quit or cut down on their smoking and
alcohol intake.
Conclusion
In conclusion, this study finds that a majority of smokers
are using some form of aid to smoking cessation and that
this primarily involves pharmacological support. Use of
face-to-face behavioural support, while free, remains low
and higher for alcohol reduction than smoking cessation.
There are important sociodemographic differences in the
use of aids to smoking cessation and alcohol use reduction.Additional file
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